scholarly journals Statistical Analysis of Rheumatoid Arthritis in Association With Demography and Biochemical Investigation

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 484.2-485
Author(s):  
M. Ferro ◽  
S. Charneca ◽  
J. Vasques ◽  
E. Dourado ◽  
C. Sousa Guerreiro ◽  
...  

Background:Rheumatoid arthritis (RA) is a chronic inflammatory disease in which an abnormal body composition was reported to be highly prevalent. (1) Bioelectrical phase angle (PhA) is a measure of the relationship between electric resistance and reactance obtained via bioelectrical impedance analysis (BIA). (2) As an indicator of cellular health, PhA has been described as a predictor of worse clinical outcome and higher mortality in various conditions. (3) Since there is evidence that PhA is related to disease progression and prognosis when considering chronic inflammatory conditions, a lower PhA may also be considered an indicator of a worse prognosis in RA. (1)Objectives:To study the association between PhA, functional status and impact of disease in RA patients.Methods:Observational and cross-sectional study, including 53 patients with RA diagnosis according to the ACR/EULAR 2010 criteria. Each patient demographic data was recorded, and body composition, including PhA by BIA, was obtained. BIA was performed using Bodystat QuadScan 4000 equipment. Functional status and impact of disease were assessed using the Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Impact of Disease (RAID) scores, respectively. PhA was stratified by tertiles (lowest, middle and highest) to create groups of patients. Statistical analysis was performed using student’s t-test (IBM SPSS version 26) for comparisons between groups.Results:A total of 53 patients with RA (81.1% women) with an average age of 62.2 ± 10.2 years were assessed. Mean PhA was 5.8 ± 1.7 °. A PhA lower than 5.2 ° (lowest tertile) was recorded in 17 patients; A PhA ranging from 5.2 ° to 6.0 ° (middle tertile) was observed in 18 patients; A PhA greater than 6.0 ° (highest tertile) was seen in 18 patients. Mean HAQ score was 1.43 ± 0.61 in the lowest tertile, 0.85 ± 0.57 in the middle tertile and 0.67 ± 0.57 in the highest tertile. Mean RAID score was 5.86 ± 1.69 in the lowest tertile, 4.73 ± 2.05 in the middle tertile and 3.00 ± 1.94 in the highest tertile. The statistical analysis showed significant differences in both HAQ and RAID scores between the lowest and the highest tertiles (p=0.001 and p <0.001, respectively). Significant differences were also found between the lowest and the middle tertile for HAQ score (p=0.007) and between the middle and the highest tertile for RAID score (p=0.017).Conclusion:In our cohort a lower PhA was significantly associated with higher HAQ and RAID scores, indicating higher disease impact and higher disability in RA patients with lower PhA. These results support the hypothesis that PhA may be investigated as a possible indicator of disease prognosis in RA.References:[1]Pineda-Juárez JA, Lozada-Mellado M, Ogata-Medel M, Hinojosa-Azaola A, Santillán-Díaz C, Llorente L, et al. Body composition evaluated by body mass index and bioelectrical impedance vector analysis in women with rheumatoid arthritis. Nutrition. 2018;53:49–53.[2]Rinaldi S, Gilliland J, O’Connor C, Chesworth B, Madill J. Is phase angle an appropriate indicator of malnutrition in different disease states? A systematic review. Clin Nutr ESPEN. 2019;29:1–14.[3]Norman K, Stobäus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis - Clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854–61.Disclosure of Interests:None declared


Author(s):  
Benjamin Onyema Eledo ◽  
Edidiong Tommy ◽  
Emmanuel Onuoha ◽  
Kingsley Dunga ◽  
Okezie Okamgba

This study determined the prevalence of Rheumatoid arthritis in elderly people that attended pilgrimage center, Elele Rivers state, Nigeria. A total of 200 subjects attending the pilgrimage center were examined for Rhematoid Factor using Latex agglutination method. The data was subjected to statistical analysis using Statistical Package for Social Sciences (SPSS) version 16.0. A prevalence of 4% was seen in the female subjects within the age bracket of 65-80 years and a prevalence of 1% was seen in the male subjects within the age bracket of 61-70 years. It showed that Rheumatoid arthritis was positive in 5% of the population and negative in 95% of the population, which was statistically significant (p< 0.05). In conclusion, there is a significant increase in the overall prevalence of rheumatoid arthritis in elderly subjects that attend pilgrimage center, Elele. Therefore proper care should be instituted to  avoid unnecessary complications associated with this ailment.


2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Line Raunsbæk Knudsen ◽  
Kirsten Lomborg ◽  
Mwidimi Ndosi ◽  
Ellen-Margrethe Hauge ◽  
Annette de Thurah

Abstract Background Patient education is integral to the treatment and care of patients with rheumatoid arthritis. Change is taking place in the organisation of healthcare systems because of a demographic shift towards ageing populations, an increasing use of technology and advancements in digital technologies, allowing for new interventions. This study will aim to evaluate the effectiveness of a newly developed e-learning patient education programme based on self-management that targets patients with rheumatoid arthritis. Methods A pragmatic multi-centre randomised controlled trial is planned. We intend to recruit approximately 200 patients with a new diagnosis (< 3 months) of rheumatoid arthritis. Participants will be randomised 1:1 to web-based patient education delivered through an e-learning programme at home or standard face-to-face patient education provided at the hospital. The primary outcome is self-efficacy. Secondary outcomes are improved knowledge of rheumatoid arthritis, adherence to medication, health literacy level and quality of life. Outcomes will be measured at baseline and follow-up occurring 1, 3, 6 and 12 months after enrolment. Furthermore, data on healthcare utilisation and utilisation of the e-learning programme will be assessed at the 12-month follow-up. Statistical analysis, including differences between groups, will be evaluated using the chi-square and Kruskal–Wallis tests. Statistical analysis will follow the intention-to-treat principle, and analysis of variance will be used to evaluate the within- and between-groups differences testing the hypothesis of the ‘superiority’ of web-based patient education over standard face-to-face education provided at the hospital. Per protocol analysis will be used to assess the impact of missing data. Enrolment started in February 2021 and will end in June 2022. Discussion The study is expected to contribute to the evidence on the effectiveness of web-based patient education within rheumatic diseases. If the e-learning programme is effective, it will be incorporated into existing services to improve the self-management of patients with rheumatoid arthritis. Further, this mode of providing patient education may impact the organisation of health care for both rheumatic diseases and other chronic diseases by offering different modes of delivering patient education based on the needs and preferences of patients. Trial registration: ClinicalTrials.gov identifier NCT04669340. Registered on November 27, 2020. https://www.clinicaltrials.gov/ct2/show/NCT04669340?term=e-learning&cond=Rheumatoid+Arthritis&draw=2&rank=1. See Additional file 1 for detailed information on the dataset according to the World Health Organization Trial Registration Data Set.


2021 ◽  
Vol 15 (1) ◽  
pp. 69-76
Author(s):  
Arash Mollaeian ◽  
Daniel S. Kim ◽  
Christopher J. Haas

Introduction: The SARS-CoV-2 global pandemic has resulted in a universal search for potential treatments of Coronavirus Disease 2019 (COVID-19). Initial reports of the therapeutic potential of chloroquine (CQ) and hydroxychloroquine (HCQ) and early non-randomized non-controlled studies were followed by subsequent trials refuting such properties. The use of CQ and HCQ in diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), prompted us to examine the prevalence of COVID-19 and proposed prophylactic and therapeutic properties of HCQ in this population. Methods: A total of 103 patients with RA and SLE aged 18 to 75 diagnosed with COVID-19 were identified. The patients were categorized as those taking HCQ (cases) and those not on HCQ (controls) for at least 6 months. Primary (mechanical ventilation, length of stay, death) and secondary outcomes were defined, data were collected, and results were compared and statistically analyzed between cases and controls. Results: No statistical difference was observed in demographic features, baseline comorbidities, and medications. Primary outcomes’ statistical analysis did not reveal any differences between cases and controls. Statistical analysis of secondary outcomes revealed that cases had a statistically higher chance of being tachypneic (p 0.034). D-Dimer (p 0.017) and LDH levels (p 0.044) were found to be significantly lower in cases versus controls. Conclusion: This study highlights the lack of clinical prophylactic and therapeutic efficacy of HCQ against COVID-19 when taken at regular doses for patients with RA and SLE. It also shows that the prevalence of COVID-19 was similar in RA and SLE patients regardless of baseline consumption of HCQ.


Author(s):  
Deepanjali T ◽  
Kiran M. Goud ◽  
Prerana Singhal

The change in life style, food habits have contributed to a number of new diseases which have become a challenge for the human race, one among such diseases is Rheumatoid arthritis which is the commonest joint disorder. It is a systemic inflammatory disease of undetermined aetiology involving primarily the synovial membrane and articular structures of multiple joint. The disease is often progressive and result in pain, stiffness and swelling of joint. In India the prevalence rate is 0.1-0.4%. The symptoms of Rheumatoid arthritis are parallel with Amavata, as the name suggests Amavata is comprise of two terms, Ama and Vata. The Nidanas such as Viruddhaahara, Viruddhacheshta, Mandagni, Nischalatva etc. due to consumption of Viruddahara and indulging in Viruddhacheshta the Ama will be manifested. The manifested ama is carried by vata and circulates throughout the body and takes ashraya in Sandhis. Commonly affecting the joints of Hasta, Pada, Shira, Gulpha, Trika, Janu and Uru and characterized by pain similar to vrischika damshtra. In this present clinical trial, 10 diagnosed patients of Amavata / Rheumatoid arthritis were selected randomly to evaluate the efficacy of Pachana Poorvaka Shodhana that is Agnilepa Chikitsa followed by Virechana Karma in Amavata w.s.r. to Rheumatoid Arthritis. Statistical analysis showed highly significant results p value (less than 0.0001) in almost all subjective and objective parameters of Amavata.


2021 ◽  
Vol 75 (Supplement_2) ◽  
pp. 7512520387p1-7512520387p1
Author(s):  
Susan McDonald ◽  
David Levine ◽  
Hensley Barnes ◽  
Anna Cornett ◽  
Caroline Craig ◽  
...  

Abstract Date Presented Accepted for AOTA INSPIRE 2021 but unable to be presented due to online event limitations. The purpose of this study was to quantify active range of motion (ROM) required for individuals with rheumatoid arthritis (RA) using built-up spoons with electrogoniometry. Statistical analysis provided quantitative evidence supporting our hypothesis that using a built-up handle requires less active ROM for grasp. Clinical implications suggest built-up handles may be used for people with other conditions with limited hand and wrist ROM, not just RA, increasing participation and independence in daily activiti Primary Author and Speaker: Susan McDonald Additional Authors and Speakers: David Levine, Hensley Barnes, Anna Cornett, Caroline Craig, Sally Langager, Lauren Yeager, and Michael Britt


Sign in / Sign up

Export Citation Format

Share Document